Cargando…
Alternative to Chemotherapy—The Unmet Demand against Leishmaniasis
Leishmaniasis is a neglected protozoan disease that mainly affects the tropical as well as subtropical countries of the world. The primary option to control the disease still relies on chemotherapy. However, a hindrance to treatments owing to the emergence of drug-resistant parasites, enormous side...
Autores principales: | Didwania, Nicky, Shadab, Md., Sabur, Abdus, Ali, Nahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742582/ https://www.ncbi.nlm.nih.gov/pubmed/29312309 http://dx.doi.org/10.3389/fimmu.2017.01779 |
Ejemplares similares
-
EBI-3 Chain of IL-35 Along With TGF-β Synergistically Regulate Anti-leishmanial Immunity
por: Asad, Mohammad, et al.
Publicado: (2019) -
Corrigendum: EBI-3 Chain of IL-35 Along With TGF-β Synergistically Regulate Anti-leishmanial Immunity
por: Asad, Mohammad, et al.
Publicado: (2019) -
Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis
por: Sabur, Abdus, et al.
Publicado: (2018) -
A Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8(+) T Cells
por: Maji, Mithun, et al.
Publicado: (2016) -
Genetically Modified Organisms and Visceral Leishmaniasis
por: Chhajer, Rudra, et al.
Publicado: (2014)